malondialdehyde has been researched along with Connective Tissue Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calis, M; Duygulu, F; Evereklioglu, C; Karabulut, AB; Turkoz, Y | 1 |
Amara, A; Chaugier, C; Conri, C; Constans, J; Dubourg, L; Geffard, M; Leng, B; Pellegrin, JL; Peuchant, E; Sebban, A | 1 |
Kudriavtseva, GV; Makarov, SA; Shishkin, VI | 1 |
3 other study(ies) available for malondialdehyde and Connective Tissue Diseases
Article | Year |
---|---|
Tumour necrosis factor alpha, lipid peroxidation and NO* are increased and associated with decreased free-radical scavenging enzymes in patients with Weill-Marchesani syndrome.
Topics: Connective Tissue Diseases; Erythrocytes; Female; Free Radical Scavengers; Genes, Dominant; Genes, Recessive; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Nitrates; Nitrites; Reference Values; Superoxide Dismutase; Syndrome; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2004 |
Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides.
Topics: Adult; Aged; Autoantibodies; Connective Tissue Diseases; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Humans; Immunoglobulin M; Male; Malondialdehyde; Middle Aged; Vasculitis | 1995 |
[Prostaglandins in the pathogenesis of various systemic diseases of the connective tissue].
Topics: Adult; Arthritis, Rheumatoid; Connective Tissue Diseases; Female; Humans; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Prostaglandins; Scleroderma, Systemic | 1987 |